Financhill
Back

MaxCyte, Inc. Stock Predictions

MaxCyte, Inc. Stock Forecast

  • Is MaxCyte, Inc. Stock Undervalued?
    The current MaxCyte, Inc. [MXCT] share price is $1.63. The Score for MXCT is 52, which is 4% above its historic median score of 50, and infers lower risk than normal.
  • MXCT is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.

Will MaxCyte, Inc. Stock Go Up Next Year?

Data Unavailable

MaxCyte, Inc. Stock Rating

Data Unavailable

MaxCyte, Inc. Stock Price History

Is MXCT stock going to rise?

  • Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and MXCT is experiencing buying pressure, which is a positive indicator for future bullish movement.

Stock Information

Stock Info

Exchange:
NASDAQ
Country:
United States
Industry:
Life Sciences Tools & Services
Sector:
Health Care
Type:
stock
Website:
maxcyte.com

52-Week Data

52-Week High:
5.20
52-Week Low:
1.26

Prediction Charts

Market Cap:
173.9M
Price in USD:
1.63
Volume:
811.9K
Beta:
0.19

Technical Analysis

SMA50:
1.60
SMA100:
1.56
SMA200:
2.02
52-Wk Change:
-61.56%

Stock Predictions

  • Is MaxCyte, Inc. stock public?
    Yes, MaxCyte, Inc. is a publicly traded company.
  • What is the MaxCyte, Inc. stock quote today?
    The MaxCyte, Inc. stock price is 1.63 USD today.
  • How to buy MaxCyte, Inc. stock online?
    You can buy MaxCyte, Inc. shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.

14-Day Historical Data

Date Opening Closing Minimum Maximum
Dec-3 1.45 1.52 1.59 1.45
Dec-4 1.51 1.58 1.62 1.50
Dec-5 1.58 1.47 1.65 1.42
Dec-8 1.49 1.55 1.61 1.49
Dec-9 1.54 1.54 1.59 1.52
Dec-10 1.53 1.54 1.57 1.50
Dec-11 1.55 1.60 1.61 1.52
Dec-12 1.61 1.52 1.61 1.50
Dec-15 1.53 1.49 1.56 1.48
Dec-16 1.49 1.47 1.54 1.47
Dec-17 1.47 1.49 1.53 1.47
Dec-18 1.51 1.52 1.54 1.51
Dec-19 1.51 1.50 1.53 1.48
Dec-22 1.51 1.63 1.65 1.50

MaxCyte, Inc. Earnings

Data Unavailable

MaxCyte, Inc. Forecast Revenue Growth

Data Unavailable

  • Analysts estimate an earnings increase this quarter of $0.04 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.03 per share, and an increase next year of $0.12 per share.

* MaxCyte, Inc. stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.